IRIS
BILANCIO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.687
NA - Nord America 2.837
AS - Asia 1.869
SA - Sud America 264
AF - Africa 22
OC - Oceania 3
Totale 9.682
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.799
RU - Federazione Russa 2.735
SG - Singapore 633
IE - Irlanda 518
IT - Italia 432
CN - Cina 406
HK - Hong Kong 275
UA - Ucraina 253
BR - Brasile 233
GB - Regno Unito 230
VN - Vietnam 204
DE - Germania 193
FI - Finlandia 111
IN - India 92
TR - Turchia 83
KR - Corea 82
SE - Svezia 65
FR - Francia 39
GR - Grecia 38
JP - Giappone 27
CA - Canada 17
BE - Belgio 16
AR - Argentina 15
BD - Bangladesh 10
MX - Messico 10
AT - Austria 9
IQ - Iraq 9
PK - Pakistan 9
NL - Olanda 8
ZA - Sudafrica 8
ES - Italia 6
ID - Indonesia 6
DK - Danimarca 5
IR - Iran 5
UZ - Uzbekistan 5
EC - Ecuador 4
MA - Marocco 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
LT - Lituania 3
PY - Paraguay 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BZ - Belize 1
CI - Costa d'Avorio 1
DM - Dominica 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 9.682
Salva come PNG Salva come JPEG
Città #
Moscow 1.002
Dublin 518
San Jose 419
Chandler 401
Jacksonville 386
Singapore 333
Santa Clara 296
Hong Kong 271
Ashburn 102
Beijing 96
Ann Arbor 92
Naples 89
Seoul 82
Bengaluru 80
Bremen 69
Princeton 68
Ho Chi Minh City 67
Medford 57
Boardman 56
Caserta 56
Wilmington 48
Hanoi 44
Hefei 42
Roxbury 37
Woodbridge 35
Helsinki 33
San Mateo 33
Dallas 25
Los Angeles 21
Frattamaggiore 20
Da Nang 19
Marano 19
Munich 18
São Paulo 17
Brussels 16
Istanbul 16
Nanjing 16
The Dalles 16
Mountain View 15
Cambridge 14
Turku 14
Frankfurt am Main 13
New York 13
Rome 12
Jinan 11
Houston 10
Hải Dương 10
Nanchang 10
Orta di Atella 10
Seattle 10
Marigliano 9
Memphis 9
Zhengzhou 9
Des Moines 8
London 8
Pozzuoli 8
Rio de Janeiro 8
Council Bluffs 7
Guangzhou 7
Kunming 7
Shenyang 7
Volla 7
Auburn Hills 6
Belo Horizonte 6
Biên Hòa 6
Castelnuovo Cilento 6
Orem 6
Tokyo 6
Toronto 6
Amsterdam 5
Atlanta 5
Bắc Ninh 5
Cabo Frio 5
Denver 5
Forino 5
Haiphong 5
Hebei 5
Milan 5
Napoli 5
Norwalk 5
Stockholm 5
Tashkent 5
Thái Nguyên 5
Araraquara 4
Aversa 4
Brooklyn 4
Columbus 4
Dhaka 4
Guarulhos 4
Hanover 4
Juiz de Fora 4
Nuremberg 4
Pannarano 4
Afragola 3
Benevento 3
Boston 3
Brasília 3
Campobasso 3
Catanzaro 3
Caxias do Sul 3
Totale 5.424
Salva come PNG Salva come JPEG
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 298
'Role of PI3-K signaling in steroid action’ 214
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 197
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 195
Effect of new androgen receptor antagonists (SARMs) in the treatment of human prostate cancer. 193
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 187
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 185
Breast cancer stem cells: The role of sex steroid receptors 185
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 183
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 180
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 180
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 174
Integrating signals between cAMP and MAPK pathways in breast cancer 172
Sex steroid hormones act as growth factors 170
Protein tyrosine phosphorylation and estradiol action 169
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 167
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 166
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 164
'Steroid-activated PI3-K pathway in target cells'. 163
Action of vanadate on estrogen dependent MCF-7 cells. 162
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 161
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 159
Rapid signalling pathway activation by androgens in epithelial and stromal cells 158
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 156
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 155
Control of axonal growth and regeneration of sensory neurons by the p110delta PI 3-kinase. 155
Phosphoinositide 3-kinase assay in breast cancer cell extracts. 151
Src is an initial target of sex steroid hormone action. 150
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 150
Androgens and NGF Mediate the Neurite-Outgrowth through Inactivation of RhoA. 149
Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. 148
Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients 145
Ruolo di PI3K p110δ nell’attivazione linfocitaria e possibili implicazioni nella leucemia. 142
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 139
Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. 137
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 137
Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages 134
The androgen receptor in breast cancer 132
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 128
Essential role for the p110delta phosphoinositide 3-kinase in the allergic response 124
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 124
Non-genomic action of steroid hormones: More questions than answers 122
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 121
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 120
Protein tyrosine phosphorylation and estradiol action 115
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. 113
Steroid activation of signal transducing pathways. 113
Signalling by PI3K isoforms: insights from gene-targeted mice 112
NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS. 112
Phosphoinositide 3-kinase in T cell activation and survival 112
Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice 110
Stat3-induced apoptosis requires a molecular switch in PI(3)K subunit composition 108
Role of PI3-kinase signaling in steroid action 107
Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells 104
Signal transduction pathway activation by estradiol in human carcinoma-derived cell lines 103
Steroid activation of signalling pathways. 103
The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells 102
PI3-K in concert with Src induces S-phase entry of an oestradiol-stimulated human breast cancer cell line 101
Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. 100
PI3-K in concert with Src induces S-phases entry of oestradiol-stimulated MCF-7 cells 100
Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells 100
Urinary neopterin and kynurenine in patients submitted to surgical stress with different inhalational anesthetics (halothane or isoflurane). 99
Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy 97
Steroid activation of signal transducing pathways. 97
The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. 96
Steroids hormones modulate DNA synthesis by non genomic action. 96
Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. 95
Non genomic action of estradiol and progestin triggers DNA synthesis. 95
Role of a PKC in estradiol-induced G1/S progression of MCF-7 cells. 93
Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models 86
Sex steroid hormones: cross-talks between receptors and signalling pathways. 83
Totale 9.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.814
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022467 37 2 4 4 151 10 10 13 22 44 35 135
2022/20231.283 76 31 11 139 152 116 9 120 559 15 28 27
2023/2024423 42 14 12 28 117 11 16 10 3 63 51 56
2024/20251.144 7 10 24 50 175 174 151 86 119 152 101 95
2025/20264.812 202 271 207 172 408 2.562 236 245 213 157 77 62
Totale 9.853